75
Participants
Start Date
July 8, 2021
Primary Completion Date
November 7, 2023
Study Completion Date
February 7, 2024
Maralixibat
A small molecule inhibitor of the ileal bile acid transporter (IBAT)
Placebo
Identical to maralixibat except for the active drug substance
Linkou Chang Gung Memorial Hospital, Taoyuan District
Taichung Veterans General Hospital, Taichung
NYU Grossman School of Medicine, New York
New York-Presbyterian - Columbia University Medical Center, New York
Montefiore Medical Center, The Bronx
Children's Hospital of Philadelphia, Philadelphia
Children's Healthcare of Atlanta - Emory University School of Medicine, Atlanta
Texas Children's Hospital, Houston
Phoenix Children's Division of Gastroenterology & Hepatology, Phoenix
Beijing Pediatric Research Institute, Beijing
Vietnam National Children's Hospital, Hanoi
Children's hospital of Shanghai, Shanghai
Children's Hospital of Fudan University, Shanghai
KK women's and Children's hospital, Bukit Timah
The Children's Hospital, Zhejiang University School of Medicine, Hanzhou
Guangzhou Women and Children's Medical Center, Guangzhou
Children's Hospital No. 1, Ho Chi Minh City
Hannover Medical School, Hanover
Instytut Pomnik-Centrum Zdrowia Dziecka, Warsaw
King's College Hospital NHS, London
Hue Central Hospital, Huế
Birmingham Children's Hospital, Birmingham
Lead Sponsor
Mirum Pharmaceuticals, Inc.
INDUSTRY